# CNS Prophylaxis in Diffuse Large B-cell Lymphoma

> **NCT02777736** · PHASE3 · UNKNOWN · sponsor: **Czech Lymphoma Study Group** · enrollment: 500 (estimated)

## Conditions studied

- Diffuse Large B-cell Lymphoma

## Interventions

- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT02777736
- **Lead sponsor:** Czech Lymphoma Study Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2018-12
- **Final completion:** 2019-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2016-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02777736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02777736, "CNS Prophylaxis in Diffuse Large B-cell Lymphoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02777736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*